ORGANIC
LETTERS
2005
Vol. 7, No. 18
3989-3992
Total Synthesis and Structural
Confirmation of ( )-Longicin
+
Stephen Hanessian,* Simon Giroux, and Maxime Buffat
Department of Chemistry, UniVersite´ de Montre´al, C.P. 6128, Succursale Centre-Ville,
Montre´al, Que´bec H3C 3J7, Canada
Received June 24, 2005
ABSTRACT
A stereocontrolled total synthesis of (+)-longicin, a representative of the class of mono-THF-acetogenins, is described. The strategy involves
the utilization of - and -glutamic acids as chirons that correspond to two five-carbon segments harboring stereogenic centers at C4 and at
D
L
C17 of the C32 polyketide-derived natural product. The use of Grubbs’ RCM reaction as a novel “chain elongation” strategy for the synthesis
of acetogenin-type structures and a new protocol for butenolide incorporation are also described.
The acetogenin family of natural products is a class of
polyketide-derived metabolites originally isolated from tropi-
cal and subtropical plants commonly known as Annonacea.1
They are usually characterized by the presence of one or
more tetrahydrofuran units embedded within a long fatty acid
chain also bearing noncontiguous secondary hydroxyl groups.
This unique class of annonaceous acetogenins, represented
by several hundred well-defined structures, has attracted
particular attention due to their broad range of physiological
effects.1,2 Tumor cell death by apoptosis due to interference
with ATP supply via inhibition of mitochondrial complex I
is among the diverse biological modes of action of the
acetogenins.3 Their antitumor activity in particular4 has
instigated intense efforts toward the stereocontrolled total
synthesis of several members of this class.5,6 Indeed, there
are a number of reported total syntheses of acetogenins that
contain a central tetrahydrofuran ring,7 as well as those with
more than one ring.8
(4) (a) Zeng, L.; Ye, Q.; Oberlies, N. H.; Shi, G.; Gu, Z.-M.; He, K.
Nat. Prod. Rep. 1996, 13, 276. (b) Oberlies, N. H.; Croy, V. L.; Harrison,
M. L.; McLaughlin, J. L. Cancer Lett. 1997, 115, 73. See also ref 1a,b.
(5) For relevant reviews, see: Hoppe, R.; Scharf, H. D. Synthesis 1995,
1447. Figade`re, B. Acc. Chem. Res. 1995, 28, 359. See also ref 1b. Marshall,
J. A.; Hinkle, K. W.; Hagedorn, C. E. Israel J. Chem. 1997, 37, 97.
(6) For a summary of synthetic approaches, see: Prestat, G.; Baylon,
C.; Heck, M.-P.; Grasa, G. A.; Nolan, S. P.; Mioskowski, C. J. Org. Chem.
2004, 69, 5770.
(7) For selected syntheses, see Solamin: (a) Trost, B. M.; Shi, Z. J. Am.
Chem. Soc. 1994, 116, 7459. (b) Sinha, S. C.; Keinan, E. J. Am. Chem.
Soc. 1993, 115, 4891. (c) Makabe, H.; Tanaka, A. J.; Oritani, T. J. Chem.
Soc. Perkin Trans. 1 1994, 1975. Kuriyama, W.; Ishigami, K.; Kitahara, T.
Heterocycles 1999, 50, 981. Corossolone: Yao, Z.-J.; W, Y.-L. J. Org.
Chem. 1995, 60, 1170. Reticulacin: ref 6b,c. Longifolicin: Marshall, J.
A.; Jiang, H. Tetrahedron Lett. 1998, 39, 1497. Murisolin: Zhang, Q.; Lu,
H.; Richard, C.; Curran, D. J. Am. Chem. Soc. 2004, 126, 36.
(8) See for example selected total syntheses: (a) Avedissian, H.; Sinha,
S. C.; Yazbak, A.; Sinha, A.; Neogi, P.; Sinha.S. C.; Keinan, E. J. Org.
Chem. 2000, 65, 6035. (b) Trost, B. A.; Calkins, T. L.; Bochet, C. G. Angew.
Chem. Int. Ed. 1997, 36, 2632. (c) Marshall, J. A.; Hinkle, K. W. J. Org.
Chem. 1997, 62, 5989. (d) Marshall, J. A.; Chem, M. J. Org. Chem. 1997,
62, 5996. (e) Wo¨krle, I.; Claben, A.; Peterek, M.; Scharf, H.-D. Tetrahedron
Lett. 1996, 37, 7001. (f) Makabe, H.; Tanimoto, H.; Tanaka, A.; Oritami,
T. Heterocycles 1997, 38, 4247. (g) Sinha, S. C.; Sinha, A.; Yazbak, A.;
Keinan. E. J. Org. Chem. 1996, 61, 7640. (h) Sinha, S. C.; Sinha, A.; Keinan,
E. J. Am. Chem Soc. 1998, 120, 4017. (i) Hoye, T. R.; Ye, Z. J. Am. Chem.
Soc. 1996, 118, 1801. (j) Naito, H.; Kawahara, E.; Maruta, M.; Sasaki, S.
J. Org. Chem. 1995, 60, 4419 and references therein.
(1) (a) Alali, F. Q.; Liu, X.-X.; McLaughlin, J. L. J. Nat. Prod. 1999,
62, 504. (b) Zafra-Polo, M.-C.; Figade`re, B.; Gallardo, T.; Tormo, J. R.;
Cortes, D. Phytochemistry 1998, 48, 1087. (c) Cave´, A.; Figade`re, B.;
Laurens, A.; Cortes, D. Progress in The Chemistry of Organic Natural
Products; Herz, W., Kirby, G.-W., Moore, R. E., Steglich, W., Tamm, Ch.,
Eds.; Springer-Verlag: New York, 1997, Vol. 70, pp 81-288. (d) Zeng.
L.; Ye, Q.; Oberlies, N. H.; Shi, G.; Gu, Z.-M.; He, K.; McLaughlin, J. L.
Nat. Prod. Rep. 1996, 13, 275.
(2) McLaughlin, J. L.; Chang, C.; Smith, D. L. Human Medicinal Agents
from Plants; Kinghorm, A. D., Balardin, M. F., Eds.; American Chemical
Society: Washington, DC, 1993; Chapter 9, p 117.
(3) See for example: (a) Gallardo, T.; Saez, J.; Granados, H.; Tormo, J.
R.; Velez, I. D.; Brun, N.; Torres, B.; Cortes, D. J. Nat. Prod. 1998, 61,
1001. (b) Oberlies, N. H.; Chang, C.-J.; McLaughlin, J. L. J. Med. Chem.
1997, 40, 2102. (c) Holligworth, R. M.; Ahmmadsahib, K. I.; Gadelhac,
G.; McLaughlin, J. L. Biochem. Soc. Trans. 1994, 22, 230.
10.1021/ol051483k CCC: $30.25
© 2005 American Chemical Society
Published on Web 08/05/2005